Philipp Mergenthaler

Philipp Mergenthaler is a neurologist and clinical neuroscientist at Charité - Universitätsmedizin Berlin, where he holds the position of Research Fellow. He is affiliated with the Department of Neurology with Experimental Neurology, the Center for Stroke Research Berlin (CSB), and the NeuroCure Clinical Research Center. His research focuses on the interplay between glucose metabolism and programmed cell death (apoptosis) in mitochondrial diseases, with implications for neurodegenerative disorders like Alzheimer’s and Parkinson’s, as well as stroke.

Key themes in his work include:

• Exploring mitochondrial dysfunction as a driver of neurodegeneration.
• Developing organoid models to study patient-specific mutations affecting glucose metabolism.
• Investigating drug therapies to delay or prevent cell death in stroke and mitochondrial diseases.

Notable scientific awards include:

• Einstein Junior Fellowship (since 2021).
• EU-FP7 Marie-Curie International Outgoing Fellowship (2014–2016).

His research bridges clinical neuroscience and experimental biology, aiming to translate findings into treatments for currently incurable conditions.